BRUSSELS: European Union lawmakers will hold a confidence vote Thursday on the head of the bloc's powerful executive arm, Ursula von der Leyen, with Hungarian Prime Minister Viktor Orbán leading calls ...

Ursula von der Leyen, the European Commission president, faces a confidence vote initiated by hard-right lawmakers, fueled by ...

Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here’s What We Know. By Ty Roush, Forbes Staff. Ty Roush is a breaking news reporter based in New York City.

The suit argued Pfizer’s statements and language surrounding the COVID-19 vaccine were a violation of the Kansas Consumer Protection Act. The state is seeking unspecified monetary damages.

"Pfizer said its COVID-19 vaccine was safe even though it knew its COVID-19 vaccine was connected to serious adverse events, including myocarditis and pericarditis, failed pregnancies, and deaths.

The Facts In November 2020, Pfizer released a statement sharing the results of its COVID-19 vaccine trials, stating that its vaccine was "95% effective against COVID-19 beginning 28 days after the ...

Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the drugmaker of misrepresenting the efficacy of its widely-used COVID-19 vaccine.

Feb. 18, 2023 – A new study shows the Pfizer vaccine is safe and highly effective against COVID-19 in children as young as 6 months old. A three-dose series of the Pfizer COVID-19 vaccine was 73 ...

Pfizer's pediatric COVID-19 vaccine has an efficacy of 80.3%, according to a preliminary analysis, and meets "all immunobridging criteria required for Emergency Use Authorization," the company ...

A Pfizer document recently released by the Food and Drug Administration describes adverse events reported following vaccination and attests to the continued safety of the company’s COVID-19 vaccine.

Pfizer is enrolling healthy adults to test a reformulated COVID-19 vaccine that matches the hugely contagious omicron variant, to see how it compares with the original shots.

Pfizer's vaccine was authorized for children 12 through 15 years of age in May of this year. This decision now makes Pfizer's the first vaccine in the country available to children under 12.